Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014

Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences
Sandra Lopez-LeonLeon Ruiter-Lopez

Abstract

There is a global perception that psychotropic utilization in children and adolescents is increasing in the US. We present prevalent estimates for all psychotropics prescribed in the US (using commercial claims from Medicare and Medicaid) to children and adolescents in 2004 (total population N = 6,808,453) and in 2014 (total population N = 11,082.260). Further we evaluated if there has been a statistically significant change in prevalence during this time period. Analyses were stratified for the 6 major drug classes, all individuals' psychotropics (87 drugs), age and sex. The prevalence of psychotropic drug prescription was 8.55% in 2004 and 9.00% in 2014 (age stratified in 2004 and 2014 toddlers: 3.08 and 2.63%, children: 8.74 and 8.73%, adolescents: 10.89% and 12.11). The prevalence for each drug class in 2004 and 2014 was: stimulants/other ADHD drugs 5.0 and 5.8%; antidepressants 2.8 and 2.7%; anxiolytic-hypnotic-sedative 2.2 and 2.3%; mood stabilizers 0.1 and 0.1%; antipsychotics 1.3 and 1.1%; and for drugs treating drug dependence 0.02 and 0.02%. The perception that psychotropic utilization in children and adolescents is increasing in the US, derived from the 2 to 3 fold increase seen from the mid 80's to the mid 90's is n...Continue Reading

References

Jan 1, 1997·Journal of Child and Adolescent Psychopharmacology·D J Safer
Jan 9, 2003·Archives of Pediatrics & Adolescent Medicine·Julie Magno ZitoMark A Riddle
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Mar 15, 2006·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·William O CooperWayne A Ray
Oct 4, 2008·Psychiatric Services : a Journal of the American Psychiatric Association·Robert Constantine, Rajiv Tandon
Mar 19, 2009·Journal of Autism and Developmental Disorders·Rebecca E RosenbergWalter E Kaufmann
Aug 7, 2009·Psychological Medicine·I TarriconeD Berardi
Oct 29, 2009·JAMA : the Journal of the American Medical Association·Christoph U CorrellAnil K Malhotra
Oct 18, 2011·Pediatrics·UNKNOWN Subcommittee on Attention-Deficit/Hyperactivity DisorderSusanna Visser
Jan 16, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Rachel KornfieldG Caleb Alexander
Nov 14, 2013·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Jun 24, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Boris LorbergTimothy Wilens
Oct 30, 2014·The New England Journal of Medicine·Richard A Friedman
Mar 4, 2015·JAMA : the Journal of the American Medical Association·Ian SchmidJulie M Zito
Apr 22, 2015·Journal of Child and Adolescent Psychopharmacology·W David LohrPatricia Gail Williams
Jul 2, 2015·JAMA Psychiatry·Mark OlfsonMichael Schoenbaum
Sep 10, 2015·The New England Journal of Medicine·Katherine J RansohoffKavita Y Sarin

❮ Previous
Next ❯

Citations

Apr 11, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Elizabeth Hisle-GormanGregory H Gorman
Aug 6, 2019·Health Affairs·Elizabeth Hisle-GormanGregory H Gorman
Jan 25, 2020·Journal of Child and Adolescent Psychopharmacology·Beate OerbeckLars Lien
Nov 24, 2020·Therapeutic Advances in Psychopharmacology·David Cohen, Alexander Recalt
Apr 29, 2021·Journal of Child and Adolescent Psychopharmacology·Lisa HutchisonYehuda Lerea
Jul 10, 2021·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Clara BothAlexander Häge
Sep 3, 2021·Psychiatric Services : a Journal of the American Psychiatric Association·W David LohrDeborah Winders Davis

❮ Previous
Next ❯

Software Mentioned

MarketScan

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2022 Meta ULC. All rights reserved